初级皮肤病中的实验室和临床血静异常:一项综述
Divya Sharma1, Sierra Thomas1,2, Trace B Moody3
1Department of Dermatology, University of Nebraska Medical Center, 985645, Omaha, NE, 68198-5645, USA.
Thrombosis journal
|November 13, 2024
概括
炎症性皮肤疾病可能会影响血栓的风险. 研究正在探索皮肤疾病和高凝血状态之间的联系,需要更多的数据来得出明确的结论.
科学领域:
- 皮肤病学和血栓瘤研究研究
- 研究皮肤疾病的系统影响.
背景情况:
- 传统上,炎症性皮肤病被认为是局部的.
- 新兴研究探讨了它们的系统性影响,包括血栓栓塞的风险.
- 关于皮肤疾病病理生理学和高凝固性,存在重大知识差距.
研究的目的:
- 审查当前关于炎症性皮肤病的文献,以及它们与血栓栓塞状态的关联.
- 为了确定潜在的分子机制,将皮肤炎症与高凝固性联系起来.
- 突出进一步研究系统性炎症和临床结果的需要.
主要方法:
- 关于炎症性皮肤疾病及其系统连接的文献综述.
- 对检查心血管并发症和高凝血状态的研究进行分析.
- 调查中的生物标志物的识别 (例如,F1+2,D-二极管,PAI-1).
主要成果:
- 有限的文献表明,炎症性皮肤疾病和高凝血状态之间存在潜在的联系.
- 具体的疾病,如牛皮,亚托皮性皮肤炎和性炎等是讨论的.
- 生物标志物正在研究以阐明连接机制,但需要进一步验证.
结论:
- 炎症性皮肤病可能不是"皮肤有限",并且可以影响全身健康.
- 更全面的研究对于理解分子机制,临床结果和干预措施至关重要.
- 研究皮肤疾病中的高凝血性对于优化患者护理至关重要.
相关概念视频
Disorders of Hemostasis
711
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
711
Extrinsic and Intrinsic Pathways of Hemostasis
5.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
Changes in Skin Color: Clinical Perspectives
1.7K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
1.7K
Introduction to Hemostasis
5.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.9K
Coagulation
4.9K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.9K


